HealthMore in Health→
Kendall Square Lab Market Shows Signs of Recovery Amid Biotech Optimism
Key Takeaways
- Kendall Square's lab market shows early recovery signs after oversupply and declining demand.
- Vacancy rates stabilize; mid-sized biotech firms sign new leases.
- Rising biotech valuations and AI-driven drug discovery boost demand.
- Challenges include high costs, sublease availability, and uneven recovery.
DE
DT Editorial Team··via statnews.com